Watch Ticker

Altimmune, Inc. Common Stock

Go to Altimmune, Inc. Common Stock Website

$3.69

0.11 (3.07%)

Live

Previous Close

$3.58

Day Range

$3.535 - $3.74

Previous Day Range

$3.565 - $3.66

Market Cap

$292.8 million USD

Day Vol.

1.7 million

Previous Day Vol.

1.9 million

Currency

USD

Primary Exchange

Nasdaq

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-bas...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Business Wire - ALT Investors Have Opportunity to Join Altimmune, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm is investigating potential securities law violations by Altimmune following a 52.18% stock drop after announcing Phase 2b trial results for pemvidutide, which were characterized as 'positive' but showed statistically insignificant improvements.

Related tickers: ALT.

Read Full Article

Pomerantz Llp - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Altimmune, Inc. - ALT

Pomerantz Law Firm is investigating potential securities fraud related to Altimmune's Phase 2b trial results for pemvidutide, which led to a 53.18% stock price drop after reporting statistically insignificant efficacy endpoints.

Related tickers: ALT.

Read Full Article

Trending Tickers

Please sign in to view